E
ME Therapeutics Holdings Inc. METX
CNSX
Recommendation
Sell
Prev Close
$8.95
Volume
--
Avg Vol (90D)
516
Market Cap
$162.96M
Dividend & Yield
--
52-Week Range
$0.75 - $9.07
P/E (TTM)
--
EPS (TTM)
-$0.0398
My Lists My Alerts
Weiss Ratings METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Good
Volatility Index Weak
Beta / Standard Deviation METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta --
Price History METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return -11.76%
30-Day Total Return -6.25%
60-Day Total Return 113.07%
90-Day Total Return 36.36%
Year to Date Total Return 87.50%
1-Year Total Return 171.74%
2-Year Total Return --
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -1.32%
52-Week Low % Change 1,093.33%
Price METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $9.07
52-Week Low Price $0.75
52-Week Low Price (Date) Sep 04, 2024
52-Week High Price (Date) Mar 04, 2025
Valuation METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 162.96M
Enterprise Value 162.11M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.04
Earnings Per Share Growth -87.87%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 238.03
Enterprise Value/Revenue (TTM) --
Price $7.50
Enterprise Value/EBITDA (TTM) -168.32
Enterprise Value/EBIT -168.16
Market Cap Category Micro Cap
Dividends and Shares METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 25.19M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 236-516-7714
Address 177 Robson Street Vancouver, BC V6B 0N3
Website www.metherapeutics.com
Country Canada
Year Founded 2014
Profitability METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -82.51%
Return on Equity --
Income Statement METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -963.10K
EBIT (TTM) -964.00K
Net Income (TTM) -917.80K
Net Income Avl. to Common (TTM) -917.80K
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 12.81%
EPS Diluted (TTM) -0.04
EPS Diluted Growth (Q YOY) 18.69%
Balance Sheet METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 946.60K
Cash Per Share (Q) $0.04
Total Current Assets (Q) 1.03M
Total Preferred Equity (Q) --
Total Equity (Q) 947.10K
Current Ratio (Q) 8.181
Book Value Per Share (Q) $0.04
Total Assets (Q) 1.11M
Total Current Liabilities (Q) 125.40K
Total Debt (Q) 79.00K
Total Liabilities (Q) 166.40K
Total Common Equity (Q) 947.10K
Cash Flow METX - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -14.30K
Cash from Financing (TTM) 1.11M
Net Change in Cash (TTM) 704.90K
Levered Free Cash Flow (TTM) -66.70K
Cash from Operations (TTM) -394.20K
Weiss Ratings